Football MatchesFootball news

MEDICAL ONGOING: Manchester United’s second transfer signing is currently undergoing medical to join the club as the attacker’s announcement is scheduled to hold tomorrow

Manchester United are closing in on the signing of Lecce left-back Patrick Dorgu amid Premier League interest.

Newcastle United, Chelsea and Tottenham Hotspur were all linked with a move for Dorgu in La Gazzetta dello Sport report earlier this season. The 20-year-old’s agent, Maurice Ogbodo, has close ties to Kieran Trippier’s representatives.

But it looks to be Manchester United who have swooped in to agree a deal with the Denmark international. Dorgu was left out of the Lecce starting line-up against Parma on Friday night with transfer expert Fabrizio Romano claiming the left-back will be travelling to Manchester on Saturday to complete his medical.

READ ALSO  "I advised Ruben Amorim to remove him from his squad last week but this guy shut me up yesterday...Obviously the best performance from any player in Premier League this season": Man City coach Pep Guardiola has named ONE Man United’s player who was superb against Liverpool yesterday

Romano posted: “Patrick Dorgu doesn’t start for Lecce against [Parma] enched on his last game for the Italian club, as he will travel to Manchester tomorrow with his agents to join #MUFC with medical booked.”

Dorgu has scored three times in 21 Serie A starts for Lecce this season but now he is set to join Manchester United in a deal worth around £30million.

Newcastle’s link with the defender can rightly be viewed with some scepticism given the club completed the permanent signing of Lewis Hall for £28million in the summer following an initial loan spell. Hall’s form at left-back has silenced any talk of further additions in the position at Newcastle.

Head coach Eddie Howe has plenty of options with Dan Burn, Lloyd Kelly, Matt Targett, Tino Livramento and Kieran Trippier all capable of playing in the position should Hall be unavailable.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
error: Content is protected !!

Adblock Detected

Disabled to continue